Clinical Trial 45796

NATIONWIDE


Summary:

Study 45796 Flyer
THE PARADIGME STUDY
This research study is testing investigational treatments (Lilotomab and Betalutin) to see how it works for people whose follicular lymphoma (FL) has returned.

Medical Condition: Follicular Lymphoma
Study duration: 5 years
Phase: IIb
Study locations: United States and Canada


Qualified Participants Must:

• Be at least 18 years of age
• Have a diagnosis of Follicular Lymphoma
• Have tried at least 2 treatments for FL
• Have used rituximab or Obinutuzumab


Qualified Participants May Receive:

Reimbursement for travel


Available At:

CLICK HERE

To view an updated list of participating research sites click
here.

 


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.